TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 NOK)
| Closing information | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Turnover |
326,030
|
312,309
|
246,685 |
| Financial expenses |
4,400
|
84
|
441 |
| Earnings before taxes |
170,299
|
178,235
|
129,675 |
| EBITDA |
175,900
|
184,725
|
134,665 |
| Total assets |
786,373
|
647,555
|
572,462 |
| Current assets |
483,409
|
337,045
|
276,319 |
| Current liabilities |
123,292
|
50,028
|
59,135 |
| Equity capital |
654,748
|
589,839
|
507,107 |
| - share capital |
651
|
644
|
596 |
| Employees (average) |
89
|
86
|
75 |
Financial ratios
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Solvency |
83.3%
|
91.1%
|
88.6% |
| Turnover per employee |
3,663
|
3,632
|
3,289 |
| Profit as a percentage of turnover |
52.2%
|
57.1%
|
52.6% |
| Return on assets (ROA) |
22.2%
|
27.5%
|
22.7% |
| Current ratio |
392.1%
|
673.7%
|
467.3% |
| Return on equity (ROE) |
26.0%
|
30.2%
|
25.6% |
| Change turnover |
10,456
|
45,959
|
13,874 |
| Change turnover % |
3%
|
17%
|
6% |
| Chg. No. of employees |
3
|
11
|
4 |
| Chg. No. of employees % |
3%
|
15%
|
6% |
Total value of public sale
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.